Evidence map›Paper›PMID 25393779›Full record

ArticleNature protocols2014

CRISPR/Cas9-mediated conversion of eGFP- into Gal4-transgenic lines in zebrafish.

Thomas O Auer, Karine Duroure, Jean-Paul Concordet, Filippo Del Bene

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Using CRISPR/Cas9 for Gene Knockout in Immunodeficient NSG Mice.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  11. Application of CRISPR/Cas9-Mediated Gene Editing in Tomato.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  12. Article
  13. Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  14. Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research.Frontiers in cell and developmental biology · 2017
    Review
  15. Article
  16. Advances and perspectives in the application of CRISPR/Cas9 in insects.Dong wu xue yan jiu = Zoological research · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas O Auer1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France. [3] Institut National de la Santé de la Recherche Médicale (INSERM) U934, Paris, France. [4] Centre for Organismal Studies Heidelberg, University of Heidelberg, Heidelberg, Germany.
Karine Duroure1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France. [3] Institut National de la Santé de la Recherche Médicale (INSERM) U934, Paris, France.
Jean-Paul Concordet1] Muséum National d'Histoire Naturelle, Paris, France. [2] CNRS UMR 7196, Paris, France. [3] INSERM U1154, Paris, France.
Filippo Del Bene1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France. [3] Institut National de la Santé de la Recherche Médicale (INSERM) U934, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we present a protocol for the conversion of eGFP-transgenic zebrafish lines into lines expressing Gal4 from the same locus. This conversion allows the in-depth analysis of the former eGFP-expressing cell population; with the Gal4-upstream activating sequence (UAS) system, diverse UAS transgenes can be transactivated. Site-specific targeting of the gene encoding eGFP is achieved using the clustered regularly interspaced short palindromic repeats/CRISPR-associated 9 (CRISPR/Cas9) system. A single-guide RNA (sgRNA) that targets eGFP is injected into embryos together with a donor vector containing an optimized version of Gal4 (KalTA4) to trigger integration of the donor into the targeted eGFP genomic location. To enable screening for successful integration events, injection is performed in a UAS:RFP transgenic background; fish showing mosaic eGFP-to-RFP conversion are raised to adulthood. The progeny of these adult fish are then screened for stable germline transmission, and converted progeny are used to generate stable lines. We have been able to generate two stably converted transgenic lines within 4 months.

Indexed as

Animals, Genetically ModifiedClustered Regularly Interspaced Short Palindromic RepeatsAnimalsEmbryo, NonmammalianGene Knock-In TechniquesGenes, ReporterGenetic EngineeringGreen Fluorescent ProteinsTransgenesZebrafishGreen Fluorescent Proteins

Identifiers

PMID25393779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.